<PAGE>
MYRIAD GENETICS, INC.
320 WAKARA WAY
SALT LAKE CITY, UTAH 84108
April 11, 2000
VIA EDGAR
- ---------
Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C. 20549
Re: Myriad Genetics, Inc. -
Registration Statement on Form S-3 (Registration No. 333-31734)
---------------------------------------------------------------
Dear Ladies and Gentlemen:
Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as
amended, Myriad Genetics, Inc. (the "Registrant") hereby respectfully requests
that the Securities and Exchange Commission consent to the withdrawal of its
Registration Statement on Form S-3 (Registration No. 333-31734), together with
all exhibits and amendments thereto (the "Registration Statement"). The
Registrant is requesting such withdrawal because of unfavorable market
conditions that would adversely affect the offering of the shares of common
stock, par value $.01 per share, covered by the Registration Statement.
The Registrant further requests that, pursuant to Rule 477(c), an order
with the date of the granting of the withdrawal be included in the file for the
above-captioned Registration Statement in the following manner: "Withdrawn upon
the request of the Registrant, the Commission consenting thereto."
Please address any questions you may have to Edward P. Gonzales, Esquire,
at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center,
Boston, Massachusetts 02111, telephone number (617) 542-6000, facsimile number
(617) 542-2241.
Thank you for your assistance with this matter.
MYRIAD GENETICS, INC.
By: /s/ Peter D. Meldrum
--------------------
Peter D. Meldrum
President and Chief Executive Officer
cc: Edward P. Gonzales, Esquire
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
